-
The Coast 2 Coast 4 Cancer Ride will raise funds and awareness in
support of Stand Up To Cancer’s efforts to accelerate research
-
Bristol-Myers Squibb will match all donations made
dollar-for-dollar up to $500,000 to support cancer patients and their
loved ones
PRINCETON, N.J.--(BUSINESS WIRE)--
Today, members of the Bristol-Myers
Squibb (NYSE:BMY) oncology team set off on the first leg of
the Coast 2 Coast 4 Cancer Ride, a 19-day bike relay that will
involve over 80 employees riding a combined total of nearly 2,900 miles,
from today’s start on the Oregon Coast to the Jersey Shore, to show
their support for the cancer community while raising funds for cancer
research. Bristol-Myers Squibb will match donations raised by the
riders, dollar-for-dollar up to $500,000, to support Stand Up To Cancer,
whose collaborative “Dream Teams” of scientific researchers are working
together to accelerate cancer research and to provide innovative
treatment to patients faster.
“This is the second consecutive year that Bristol-Myers Squibb employees
are making this remarkable effort for Coast 2 Coast 4 Cancer.
Most of our cyclists are riding for people they know whose lives have
been touched by this disease, and the teams’ dedication reflects our
commitment to helping cancer patients across the country,” said Teresa
Bitetti, senior vice president, U.S. Oncology, Bristol-Myers Squibb.
“The strength and passion of our employees make it possible for us to
strive toward changing the way cancer is treated, and those same
qualities inspire us to reach the Coast 2 Coast 4 Cancer finish
line on behalf of the cancer community.”
In addition to the Coast 2 Coast 4 Cancer Ride, Bristol-Myers
Squibb has a significant history of providing support to Stand Up To
Cancer to advance cancer research, awareness and patient care. “We are
very impressed by the Bristol-Myers Squibb employees who are cycling
this year and are grateful for their support of the Stand Up To Cancer
movement,” said Stand Up To Cancer Co-Founder Katie Couric. “Their
commitment to our dream of making every person diagnosed with cancer a
survivor is inspiring for all of us, and we are proud to be a part of
the larger Coast 2 Coast 4 Cancer team.”
Last year, Coast 2 Coast 4 Cancer riders raised $359,000 for
Stand Up To Cancer research and this year’s ride is even more ambitious,
with six teams of 11-14 riders each, covering approximately 450 miles
per team. “I am riding for my mom who battled cancer. She was my best
friend and if I have achieved anything in this life, it is because of
her. This race is about the patients we serve, their families, their
doctors and their nurses who fight every day for them,” said E.
G. “Bubba” Klugh, Bristol-Myers Squibb, Little Rock, AR. “The
training leading up to our ride has been strenuous, but the discipline
required is part of what makes Coast 2 Coast 4 Cancer so
meaningful to the riders because we are riding for patients. We would
all ride as far as it takes – for them.”
For more information on how you can show your support for Coast 2
Coast 4 Cancer, visit www.cancerbikeride.org.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information, visit www.bms.com
or follow us on Twitter at http://twitter.com/bmsnews.
About Stand Up To Cancer
Stand Up To Cancer is a program of the Entertainment Industry
Foundation, a 501(c)(3) charitable organization, whose collaborative
Dream Teams of investigators from different institutions and across
disciplines are working together to translate their research from the
laboratory to the clinic – where it can help patients – as quickly as
possible. Donations fund Stand Up To Cancer’s innovative research
focused on bringing new, innovative treatments to patients faster,
making cancer patients, cancer survivors.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150910005482/en/
Source: Bristol-Myers Squibb